Alvine Pharmaceuticals Announces Positive Results from Phase 1 Clinical Trial of ALV003, Therapy in Development for Celiac Disease

SAN CARLOS, Calif., October 29, 2008 – Alvine Pharmaceuticals, Inc. today announced that it has proven its concept in a

read more